primary carcinoma

pri·mar·y car·ci·no·ma

carcinoma at the site of origin, with local invasion in that organ.

primary carcinoma

a neoplasm at the site of origin.

pri·mar·y car·ci·no·ma

(prīmār-ē kahr-si-nōmă)
Cancer at the site of origin, with local invasion in that organ.
References in periodicals archive ?
Primary carcinoma originating in the Littre glands.
The patient had only recently been diagnosed with his primary carcinoma.
Of these, 14 cases met the criteria of being from patients with a diagnosis of UCa who subsequently developed a lung lesion and who lacked the diagnosis of a precedent or subsequent primary carcinoma at other anatomic sites.
In fact, nearly all cases of primary carcinoma of the spleen were reported before 1923, before technologies had developed to allow distinction between carcinomas and sarcomas (5).
A thorough history taking, physical examination, FNAC of the palpable axillary lymph node, Chest X-ray, ultrasound of the abdomen, screening blood work, mammogram and /or Magnetic resonance imaging (MRI) of the breast are sufficient as the recommended investigations for locating potential sites of primary carcinoma.
At the time, the differential diagnosis was carcinoid tumour, primary carcinoma and a metastatic lesion (from the known primary tubal carcinoma).
Squamous cell carcinoma antigen as an adjunct tumour marker in primary carcinoma of the lung.
Each year, primary carcinoma of the lungs affects 93,000 men and 80,000 women in the United States and 86 percent die within five years of diagnosis.
Metastatic carcinoma of the jaws secondary to primary carcinoma of the breast.
The existence of a primary carcinoma (Figure 7) arising within a BCC remains controversial.
0026%, that a mass under 3 cm therefore has a very low chance of being a primary carcinoma, and that a mass greater than 6 cm has a higher likelihood of being a malignancy.
Studies included three ongoing trials of nab-paclitaxel in the treatment of triple-negative breast cancer (TNBC), HER2-negative primary operable breast cancer, and elderly patients with an increased risk for relapse of a primary carcinoma of the breast, continuing the company's focus on developing treatments for difficult-to-treat cancers.

Full browser ?